1207472-10-3

Upstream product

• 1207472-08-9 1-(2,6-difluoro-4-nitrophenyl)-4-methoxymethyl-piperidin-4-ol 
• 1207472-09-0 6-(2,6-difluoro-4-nitrophenyl)-1-oxa-6-azaspiro[2.5]octane 
• 565459-90-7 1-(2,6-difluoro-4-nitrophenyl)piperidin-4-one 
• 66684-58-0 3,4,5-trifluoronitrobenzene 
• 41979-39-9 4-piperidone hydrochloride 

Downstream Products

• 957796-51-9 (5S)-N-{3-[3,5-difluoro-4-(4-hydroxy-4-methoxymethyl-piperidin-1-yl)phenyl]-2-oxo-oxazolidin-5-ylmethyl}-acetamide 
• 1016650-82-0 phosphoric acid mono-(1-{4-[(S)-5-(acetylamino-methyl)-2-oxo-oxazolidin-3-yl]-2,6-difluorophenyl}-4-methoxymethyl-piperidin-4-yl) ester 
• 1016651-07-2 (S)-N-{3-[3,5-difluoro-4-(4-hydroxy-4-methoxymethyl-4-di-O-benzylphosphoryloxy-piperidin-1-yl)-phenyl]-2-oxo-oxazolidin-5-ylmethyl}-acetamide 
• 1207472-06-7 (5R)-3-[3,5-difluoro-4-(4-hydroxy-4-methoxymethyl-piperidin-1-yl)-phenyl]-5-hydroxymethyl-oxazolidin-2-one 
• 1207472-07-8 (5R)-methanesulfonic acid 3-[3,5-difluoro-4-(4-hydroxy-4-methoxymethyl-piperidin-1-yl)-phenyl]-2-oxo-oxazolidin-5-ylmethyl ester 
• 1207472-12-5 (5R)-3-[3,5-difluoro-4-(4-hydroxy-4-methoxymethyl-piperidin-1-yl)-phenyl]-5-azidomethyl-oxazolidin-2-one 
• 1207472-14-7 (5S)-N-2-{3-[3,5-difluoro-4-(4-hydroxy-4-methoxymethyl-piperidin-1-yl)-phenyl]-2-oxo-oxazolidin-5-ylmethyl}-phthalimide 
• 1207472-13-6 5-aminomethyl-3-[3,5-difluoro-4-(4-hydroxy-4-methoxymethyl-piperidin-1-yl)-phenyl]-oxazolidin-2-one 

Relevant academic research and scientific papers

PROCESS FOR THE PREPARATION OF PHOSPHORIC ACID MONO- (L-{4- [(S) -5- (ACETYLAMINOMETHYL) - 2 - OXO - OXAZOLIDIN- 3 - YL] - 2, 6 - DIFLUOROPHENYL} - 4 -METHOXYMETHYLPIPERIDIN- 4 - YL) ESTER

The invention relates to a process to prepare pharmacologically active phosphoric acid mono-(1-{4-[(S)-5-(acetylamino-methyl)-2-oxo-oxazolidin-3-yl]-2,6-difluoro phenyl}-4-methoxy methyl-piperidin-4-yl) ester.